CorVel Corp. Common Stock (CRVL)

FairStock Score: 53/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable businesses, honest numbers, and a price that leaves room for error. CorVel is a steady insurance-services operator. In FY2026, the year ended 2026-03-31, revenue was $958.5 million, net income $110.3 million, and diluted EPS $2.14. That was up from FY2025 revenue of $895.6 million, net income of $95.2 million, and diluted EPS of $1.83, and well above FY2024 revenue of $795.3 million, net income of $76.3 million, and diluted EPS of $1.47. The latest filed quarter, fiscal Q1 2027 ended 2026-06-30, showed revenue of $259.9 million, net income of $32.2 million, and diluted EPS of $0.63, ahead of fiscal Q1 2026's $234.7 million, $27.2 million, and $0.52. The balance sheet is conservative: the FairStock-calculated debt-to-equity ratio is 0.07 and Altman Z-Score is 11.64. Returns are high: FairStock calculates ROE of 30.70% and ROCE of 14.68%, though the TTM FCF yield is only 2.9%. The problem is price. At the 2026-10-13 close of $78.81, FairStock calculates a P/E of 35.03, P/B of 9.75, PEG of 2.01, and EV/EBITDA of 20.39. Its Graham Number is $20.22, leaving a margin of safety of -289.76%. The Piotroski F-Score is 6/9 and FairStock Score is 53/100. This is a good business, but the stock already reflects much of the good news. I would want the growth to continue and the multiple to come down before calling it a bargain.

In plain English: CorVel helps insurance companies and employers manage workers' compensation and health-care bills. The business looks strong: sales and profits are rising, it carries little debt, and cash flow is positive. But the stock price looks expensive compared with those profits and the company's book value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2027 10-Q (period ended 2026-06-30) · fiscal Q3 2026 10-Q (period ended 2025-12-31) · fiscal Q2 2026 10-Q (period ended 2025-09-30) · fiscal Q1 2026 10-Q (period ended 2025-06-30) · FY2026 10-K (period ended 2026-03-31) · FY2025 10-K (period ended 2025-03-31) · FY2024 10-K (period ended 2024-03-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer